Medeligo 1.5.4

Medeligo® offers immediate access to the most recent oncology literature and information across all subspecialties, covering treatment, procedures, testing, and management.

Fingertip Access to the Latest Oncology Information

• AI-powered search functionality built by technologists and medical librarians
• User-friendly interface for quick access to information
• Encompasses over 2,000 solid tumors and cancers, following the WHO Classification of Tumours
• Real-time searches for up-to-date information
• Searches conducted solely within reputable medical journals, databases, and information sources
• Access to primary source material: unfiltered, unbiased, and uncurated

Benefits:

• Effortlessly find and review the latest oncology publications in mere seconds
• View pertinent videos and explore images
• Enhance preparation for patient rounds, consultations, and surgeries
• Quickly address patient-specific inquiries during tumor board discussions
• Share, print, or save articles with ease

Take advantage of the limited-time introductory price of $49.99 for the All Access (1-year) subscription — originally valued at $149.99 — which also includes a risk-free 3-month trial.

To discover more, please visit www.medeligo.com.

Following the trial period, your subscription will auto-renew at $49.99 annually, charged to your iTunes account. If you decide not to continue after the free trial, remember to disable auto-renew in your Account Settings at least 24 hours before it concludes.

Subscriptions are set to renew automatically upon expiry unless you opt out of auto-renewal at least 24 hours before your subscription ends. Your account will be charged $49.99 for renewal within 24 hours preceding the conclusion of your subscription term. You can manage your subscription status and turn off auto-renew via your Account Settings.

If a free trial period was provided and a user proceeds to subscribe to that publication, any remaining free trial time will be lost where applicable.

You can review our terms and conditions:

• Privacy Policy
• Terms of Service